Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
21.18
-0.93 (-4.21%)
May 29, 2026, 12:24 PM EDT - Market open
Castle Biosciences Market Cap
Castle Biosciences has a market cap or net worth of $642.39 million as of May 29, 2026. Its market cap has increased by 30.57% in one year.
Market Cap
642.39M
Enterprise Value
445.63M
1-Year Change
30.57%
Ranking
Category
Stock Price
$21.18
Market Cap Chart
Since July 25, 2019, Castle Biosciences's market cap has increased from $123.05M to $642.39M, an increase of 422.05%. That is a compound annual growth rate of 27.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 644.81M | -43.21% |
| Dec 31, 2025 | 1.14B | 52.12% |
| Dec 31, 2024 | 746.39M | 28.53% |
| Dec 29, 2023 | 580.73M | -6.38% |
| Dec 30, 2022 | 620.32M | -43.76% |
| Dec 31, 2021 | 1.10B | -32.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adaptive Biotechnologies | 2.22B |
| GeneDx Holdings | 1.43B |
| NeoGenomics | 1.25B |
| CareDx | 1.14B |
| Personalis | 993.80M |
| OPKO Health | 981.62M |
| Fulgent Genetics | 508.37M |
| Myriad Genetics | 371.18M |